Goldman Sachs’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-137,520
| Closed | -$2.26M | – | 5019 |
|
|
2023
Q4 | $2.26M | Buy |
+137,520
| New | +$2.26M | ﹤0.01% | 3121 |
|
|
2023
Q3 | – | Sell |
-28,364
| Closed | -$148K | – | 5031 |
|
|
2023
Q2 | $148K | Buy |
28,364
+52
| +0.2% | +$271 | ﹤0.01% | 4482 |
|
|
2023
Q1 | $152K | Buy |
28,312
+26,290
| +1,300% | +$141K | ﹤0.01% | 4595 |
|
|
2022
Q4 | $7.5K | Buy |
+2,022
| New | +$7.5K | ﹤0.01% | 4969 |
|
|
2022
Q2 | – | Sell |
-3,679
| Closed | -$26K | – | 5917 |
|
|
2022
Q1 | $26K | Sell |
3,679
-3,654
| -50% | -$25.8K | ﹤0.01% | 5578 |
|
|
2021
Q4 | $97K | Buy |
7,333
+4,199
| +134% | +$55.5K | ﹤0.01% | 5232 |
|
|
2021
Q3 | $72K | Buy |
3,134
+353
| +13% | +$8.11K | ﹤0.01% | 5117 |
|
|
2021
Q2 | $122K | Buy |
2,781
+487
| +21% | +$21.4K | ﹤0.01% | 5069 |
|
|
2021
Q1 | $167K | Sell |
2,294
-26,862
| -92% | -$1.96M | ﹤0.01% | 4896 |
|
|
2020
Q4 | $1.26M | Buy |
29,156
+23,323
| +400% | +$1.01M | ﹤0.01% | 3329 |
|
|
2020
Q3 | $240K | Sell |
5,833
-11,361
| -66% | -$467K | ﹤0.01% | 4001 |
|
|
2020
Q2 | $1.03M | Buy |
17,194
+11,122
| +183% | +$668K | ﹤0.01% | 3202 |
|
|
2020
Q1 | $457K | Buy |
6,072
+3,609
| +147% | +$272K | ﹤0.01% | 3542 |
|
|
2019
Q4 | $339K | Buy |
2,463
+1,059
| +75% | +$146K | ﹤0.01% | 3818 |
|
|
2019
Q3 | $167K | Buy |
+1,404
| New | +$167K | ﹤0.01% | 3955 |
|